We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Court Backs Biosimilars of Roche’s Herceptin With Reservations
Indian Court Backs Biosimilars of Roche’s Herceptin With Reservations
Despite grave doubts, an Indian high court judge is allowing two drugmakers to market and produce contested biosimilars of Roche’s breast cancer therapy Herceptin.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor